[Consensus on Application of Third-generation EGFR-TKI in EGFR Mutated NSCLC  (2022 Version)].

Chinese Society Of Clinical Oncology (Csco) Non-Small Cell Lung Cancer Committee , Anti-Cancer Drug Safety Management Committee (Asmc)

https://doi.org/10.3779/j.issn.1009-3419.2022.101.47

Copy DOI

Journal: Chinese Journal of Lung Cancer	Publication Date: Sep 20, 2022
Citations: 2	License type: CC BY 3.0

Abstract

【中文题目：三代EGFR-TKI在EGFR突变NSCLC治疗中应用的专家共识（2022年版）】【中文关键词：肺肿瘤；受体蛋白酪氨酸激酶；ErbB受体；共识】.

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author